Double-blind Randomized Controlled Clinical Trial of Butenafine Hydrochloride 1% Cream in the Treatment of Tinea Corporis and Cruris and Tinea Pedis

汪科,王爱平,李春阳,赵广,万喆,余进,李若瑜
DOI: https://doi.org/10.3969/j.issn.1001-6821.2004.04.004
2004-01-01
Abstract:Objective To study the efficacy and safety of butenafine hydrochloride1% cream in the treatment of tinea corporis and cruris and tinea pedis. MethodsButenafine hydrochloride 1% cream was compared with bifonazole 1% cream andwas applied once daily for 2 weeks in the treatment of tinea corporis and cruris andfor 4 weeks in the treatment of tinea pedis, both treatment groups had 2 weeks offollow-up observation after the end of treatment. Results Overall cure rates for tineacorporis and cruris at follow-up 2 weeks 81.0% in trial group and 70.5% in controlgroup; overall effective rates were 98.3% versus 91.8%, respectively. Overall curerates for tinea pedis at follow-up 2 weeks 47.6% in trial group and 50.8% in controlgroup; overall effective rates were 93.6% versus93.6%, respectively. The improvedrates between two groups had no statistic differences(P0.05). Conclusion Butenafinehydrochloride 1% cream is a topical drug with good efficacy, safety and tolerabilityin the treatment of tinea corporis and cruris and tinea pedis.
What problem does this paper attempt to address?